Epigenetics and cancer: Towards an evaluation of the impact of environmental and dietary factors

Mutagenesis

Volumn 22, Issue 2, 2007, Pages 91-103

  Herceg, Zdenko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALCOHOL; ARSENIC; NICKEL; TOBACCO SMOKE;

AGING; CANCER CELL; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; DIET; DNA METHYLATION; DNA REPAIR; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE ACTIVATION; GENE SILENCING; GENOME ANALYSIS; HUMAN; LIFESTYLE; MEDICAL RESEARCH; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; SMOKING; TUMOR SUPPRESSOR GENE;

ANIMALS; DIET; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; HISTONES; HUMANS; NEOPLASMS;

EID: 33847613305     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gel068     Document Type: Review

References (179)

1. Jaenisch, R. and Bird, A. (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet., 33 (Suppl), 245-254.
2. Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
3. Jones, P. A. and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev., 3, 415-428.
4. Egger, G., Liang, G., Aparicio, A. and Jones, P. A. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457-463.
5. Jenuwein, T. and Allis, C. D. (2001) Translating the histone code. Science, 293, 1074-1080.
6. Strahl, B. D. and Allis, C. D. (2000) The language of covalent histone modifications. Nature, 403, 41-45.
7. Turner, B. M. (2002) Cellular memory and the histone code. Cell, 111, 285-291.
8. Kurdistani, S. K. and Grunstein, M. (2003) Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol., 4, 276-284.
9. Loizou, J. I., Murr, R., Finkbeiner, M. G., Sawan, C., Wang, Z. Q. and Herceg, Z. (2006) Epigenetic information in chromatin: the code of entry for DNA repair. Cell Cycle, 5, 696-701.
10. Johnson, L., Cao, X. and Jacobsen, S. (2002) Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr. Biol., 12, 1360-1367.
11. Soppe, W. J., Jasencakova, Z., Houben, A., Kakutani, T., Meister, A., Huang, M. S., Jacobsen, S. E., Schubert, I. and Fransz, P. F. (2002) DNA methylation controls histone H3 lysine 9 methylation and heterochromatin assembly in Arabidopsis. EMBO J., 21, 6549-6559.
12. Lehnertz, B., Ueda, Y., Derijck, A. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T. and Peters, A. H. (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol., 13, 1192-1200.
13. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
14. Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L. and Kouzarides, T. (2000) DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet., 24, 88-91.
15. Bird, A. P. and Wolffe, A. P. (1999) Methylation-induced repression-belts, braces, and chromatin. Cell, 99, 451-454.
16. Cameron, E. E., Bachman, K. E., Myohanen, S., Herman, J. G. and Baylin, S. B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet., 21, 103-107.
17. Wolffe, A. P. (2001) Chromatin remodeling: why it is important in cancer. Oncogene, 20, 2988-2990.
18. Rowley, J. D. (1998) The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet., 32, 495-519.
19. Cairns, B. R. (2001) Emerging roles for chromatin remodeling in cancer biology. Trends Cell Biol., 11, S15-S21.
20. Yang, X. J. (2004) The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res., 32, 959-976.
21. Belinsky, S. A. (2004) Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer, 4, 707-717.
22. Feinberg, A. P. and Tycko, B. (2004) The history of cancer epigenetics. Nat. Rev. Cancer, 4, 143-153.
23. Ushijima, T. (2005) Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer, 5, 223-231.
24. Laird, P. W. (2003) The power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3, 253-266.
25. Lund, A. H. and van Lohuizen, M. (2004) Epigenetics and cancer. Genes Dev., 18, 2315-2335.
26. Esteller, M. (2005) DNA methylation and cancer therapy: new developments and expectations. Curr. Opin. Oncol., 17, 55-60.
27. Callinan, P. A. and Feinberg, A. P. (2006) The emerging science of epigenomics. Hum. Mol. Genet., 15, R95-R101.
28. Feinberg, A. P., Ohlsson, R. and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer. Nat. Rev., 7, 21-33.
29. Jiang, Y. H., Bressler, J. and Beaudet, A. L. (2004) Epigenetics and human disease. Annu. Rev. Genomics Hum. Genet., 5, 479-510.
30. Maier, S. and Olek, A. (2002) Diabetes: a candidate disease for efficient DNA methylation profiling. J. Nutr., 132, 2440S-2443S.
31. McKinsey, T. A. and Olson, E. N. (2004) Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet., 20, 206-213.
32. Fraga, M. F., Ballestar, E., Villar-Garea, A. et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet., 37, 391-400.
33. Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M. and Kurdistani, S. K. (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435, 1262-1266.
34. Nephew, K. P. and Huang, T. H. (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett., 190, 125-133.
35. Ehrlich, M., Gama-Sosa, M. A., Huang, L. H., Midgett, R. M., Kuo, K. C., McCune, R. A. and Gehrke, C. (1982) Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res., 10, 2709-2721.
36. Richardson, B. (2003) Impact of aging on DNA methylation. Ageing Res. Rev., 2, 245-261.
37. Jones, P. A. and Martienssen, R. (2005) A blueprint for a human epigenome project: the AACR human epigenome workshop. Cancer Res., 65, 11241-11246.
38. Feinberg, A. P. and Vogelstein, B. (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 301, 89-92.
39. Adorjan, P., Distler, J., Lipscher, E. et al. (2002) Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res., 30, e21.
40. Sato, N., Maitra, A., Fukushima, N., van Heek, N. T., Matsubayashi, H., Iacobuzio-Donahue, C. A., Rosty, C. and Goggins, M. (2003) Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res., 63, 4158-4166.
41. Cho, B., Lee, H., Jeong, S., Bang, Y. J., Lee, H. J., Hwang, K. S., Kim, H. Y., Lee, Y. S., Kang, G. H. and Jeoung, D. I. (2003) Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem. Biophys. Res. Commun., 307, 52-63.
42. Qu, G. Z., Grundy, P. E., Narayan, A. and Ehrlich, M. (1999) Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet. Cytogenet., 109, 34-39.
43. Roberts, C. W. and Orkin, S. H. (2004) The SWI/SNF complex-chromatin and cancer. Nat. Rev. Cancer, 4, 133-142.
44. Peterson, C. L. and Cote, J. (2004) Cellular machineries for chromosomal DNA repair. Genes Dev., 18, 602-616.
45. Jazayeri, A., McAinsh, A. D. and Jackson, S. P. (2004) Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair. Proc. Natl. Acad. Sci. USA, 101, 1644-1649.
46. Murr, R., Loizou, J. I., Yang, Y. G., Cuenin, C., Li, H., Wang, Z. Q. and Herceg, Z. (2006) Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat. Cell Biol., 8, 91-99.
47. Herceg, Z. and Wang, Z. Q. (2005) Rendez-vous at mitosis: TRRAPed in the chromatin. Cell Cycle, 4, 383-387.
48. Carrozza, M. J., Utley, R. T., Workman, J. L. and Cote, J. (2003) The diverse functions of histone acetyltransferase complexes. Trends Genet., 19, 321-329.
49. Peto, J. (2001) Cancer epidemiology in the last century and the next decade. Nature, 411, 390-395.
50. Doll, R. and Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66, 1191-1308.
51. Mathers, J. C. (2004) The biological revolution - towards a mechanistic understanding of the impact of diet on cancer risk. Mutat. Res., 551, 43-49.
52. Feil, R. (2006) Environmental and nutritional effects on the epigenetic regulation of genes. Mutat. Res., 600, 46-57.
53. Sheldon, C. C., Rouse, D. T., Finnegan, E. J., Peacock, W. J. and Dennis, E. S. (2000) The molecular basis of vernalization: the central role of FLOWERING LOCUS C (FLC). Proc. Natl. Acad. Sci. USA, 97, 3753-3758.
54. Gendall, A. R., Levy, Y. Y., Wilson, A. and Dean, C. (2001) The VERNALIZATION 2 gene mediates the epigenetic regulation of vernalization in Arabidopsis. Cell, 107, 525-535.
55. Sutherland, J. E. and Costa, M. (2003) Epigenetics and the environment. Ann. N. Y. Acad. Sci., 983, 151-160.
56. Jablonka, E. (2004) Epigenetic epidemiology. Int. J. Epidemiol., 33, 929-935.
57. Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B. and Herman, J. G. (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. USA., 95, 11891-11896.
58. Belinsky, S. A., Palmisano, W. A., Gilliland, F. D. et al. (2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res., 62, 2370-2377.
59. Pulling, L. C., Vuillemenot, B. R., Hutt, J. A., Devereux, T. R. and Belinsky, S. A. (2004) Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res., 64, 3844-3848.
60. Okoji, R. S., Yu, R. C., Maronpot, R. R. and Froines, J. R. (2002) Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice. Carcinogenesis, 23, 777-785.
61. Takiguchi, M., Achanzar, W. E., Qu, W., Li, G. and Waalkes, M. P. (2003) Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res., 286, 355-365.
62. Conway, K. and Costa, M. (1989) Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells. Cancer Res., 49, 6032-6038.
63. Klein, C. B., Conway, K., Wang, X. W., Bhamra, R. K., Lin, X. H., Cohen, M. D., Annab, L., Barrett, J. C. and Costa, M. (1991) Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science, 251, 796-799.
64. Belinsky, S. A., Klinge, D. M., Liechty, K. C., March, T. H., Kang, T., Gilliland, F. D., Sotnic, N., Adamova, G., Rusinova, G. and Telnov, V. (2004) Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis, 25, 1063-1067.
65. van Doorn, R., Gruis, N. A., Willemze, R., van der Velden, P. A. and Tensen, C. P. (2005) Aberrant DNA methylation in cutaneous malignancies. Semin. Oncol., 32, 479-487.
66. Mittal, A., Piyathilake, C., Hara, Y. and Katiyar, S. K. (2003) Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia, 5, 555-565.
67. Pufulete, M., Al-Ghnaniem, R., Leather, A. J., Appleby, P., Gout, S., Terry, C., Emery, P. W. and Sanders, T. A. (2003) Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology, 124, 1240-1248.
68. Heijmans,B. T., Boer, J. M., Suchiman, H. E., Cornelisse,C. J., Westendorp, R. G., Kromhout, D., Feskens, E. J. and Slagboom, P. E. (2003) A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res., 63, 1249-1253.
69. Poirier, L. A. (2002) The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. J. Nutr., 132, 2336S-2339S.
70. James, S. J., Melnyk, S., Pogribna, M., Pogribny, I. P. and Caudill, M. A. (2002) Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr., 132, 2361S-2366S.
71. de Capoa, A., Musolino, A., Della Rosa, S., Caiafa, P., Mariani, L., Del Nonno, F., Vocaturo, A., Donnorso, R. P., Niveleau, A. and Grappelli, C. (2003) DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol. Rep., 10, 545-549.
72. Li, H. and Minarovits, J. (2003) Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res., 89, 133-156.
73. Kane, M. F., Loda, M., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M. and Kolodner, R. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57, 808-811.
74. Herman, J. G., Umar, A., Polyak, K. et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA, 95, 6870-6875.
75. Esteller, M., Sparks, A., Toyota, M. et al. (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res., 60, 4366-4371.
76. Esteller, M., Risques, R. A., Toyota, M., Capella, G., Moreno, V., Peinado, M. A., Baylin, S. B. and Herman, J. G. (2001) Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res., 61, 4689-4692.
77. Chen, J. X., Zheng, Y., West, M. and Tang, M. S. (1998) Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res., 58, 2070-2075.
78. Denissenko, M. F., Pao, A., Tang, M. and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-432.
79. Yoon, J. H., Smith, L. E., Feng, Z., Tang, M., Lee, C. S. and Pfeifer, G. P. (2001) Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res., 61, 7110-7117.
80. Downs, J. A., Allard, S., Jobin-Robitaille, O., Javaheri, A., Auger, A., Bouchard, N., Kron, S. J., Jackson, S. P. and Cote, J. (2004) Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol. Cell, 16, 979-990.
81. Tamburini, B. A. and Tyler, J. K. (2005) Localized histone acetylation and deacetylation triggered by the homologous recombination pathway of double-strand DNA repair. Mol. Cell. Biol., 25, 4903-4913.
82. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J. and Wolffe, A. P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
83. Doll, R. and Hill, A. B. (1950) Smoking and carcinoma of the lung; preliminary report. Br. Med. J., 2, 739-748.
84. Doll, R. and Hill, A. B. (1952) A study of the aetiology of carcinoma of the lung. Br. Med. J., 2, 1271-1286.
85. Wynder, E. L. and Graham, E. A. (1950) Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J. Am. Med. Assoc., 143, 329-336.
86. Wistuba, I. I., Mao, L. and Gazdar, A. F. (2002) Smoking molecular damage in bronchial epithelium. Oncogene, 21, 7298-7306.
87. Pfeifer, G. P., Denissenko, M. F., Olivier, M., Tretyakova, N., Hecht, S. S. and Hainaut, P. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene, 21, 7435-7451.
88. Hainaut, P. and Pfeifer, G. P. (2001) Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis, 22, 367-374.
89. IARC Monographs programme on the evaluation of the carcinogenic risk of chemicals to humans. Preamble. IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 39, 13-32.
90. Hoffmann, D., Hoffmann, I. and El-Bayoumy, K. (2001) The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol., 14, 767-790.
91. Rubin, H. (2001) Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis, 22, 1903-1930.
92. Osada, H. and Takahashi, T. (2002) Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene, 21, 7421-7434.
93. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G. and Belinsky, S. A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60, 5954-5958.
94. Chromium, nickel and welding. IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 49. World Health Organization (ed.), International Agency for Research on Cancer, 1-648.
95. Broday, L., Cai, J. and Costa, M. (1999) Nickel enhances telomeric silencing in Saccharomyces cerevisiae. Mutat. Res., 440, 121-130.
96. Broday, L., Peng, W., Kuo, M. H., Salnikow, K., Zoroddu, M. and Costa, M. (2000) Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res., 60, 238-241.
97. Zoroddu, M. A., Kowalik-Jankowska, T., Kozlowski, H., Molinari, H., Salnikow, K., Broday, L. and Costa, M. (2000) Interaction of Ni(II) and Cu(II) with a metal binding sequence of histone H4: AKRHRK, a model of the H4 tail. Biochim. Biophys. Acta, 1475, 163-168.
98. Bal, W., Liang, R., Lukszo, J., Lee, S. H., Dizdaroglu, M. and Kasprzak, K. S. (2000) Ni(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms an oxidative damage-mediating complex with the cleaved-off octapeptide. Chem. Res. Toxicol., 13, 616-624.
99. Karaczyn, A. A., Bal, W., North, S. L., Bare, R. M., Hoang, V. M., Fisher, R. J. and Kasprzak, K. S. (2003) The octapeptidic end of the C-terminal tail of histone H2A is cleaved off in cells exposed to carcinogenic nickel(II). Chem. Res. Toxicol., 16, 1555-1559.
100. Karaczyn, A. A., Golebiowski, F. and Kasprzak, K. S. (2005) Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II). Chem. Res. Toxicol., 18, 1934-1942.
101. Ke, Q., Davidson, T., Chen, H., Kluz, T. and Costa, M. (2006) Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis, 27, 1481-1488.
102. Sutherland, J. E., Peng, W., Zhang, Q. and Costa, M. (2001) The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. Mutat. Res., 479, 225-233.
103. Zhang, Q., Salnikow, K., Kluz, T., Chen, L. C., Su, W. C. and Costa, M. (2003) Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. Toxicol. Appl. Pharmacol., 192, 201-211.
104. Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P. and Waalkes, M. P. (1997) Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA, 94, 10907-10912.
105. Chen, H., Liu, J., Zhao, C. Q., Diwan, B. A., Merrick, B. A. and Waalkes, M. P. (2001) Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol., 175, 260-268.
106. Maekita, T., Nakazawa, K., Mihara, M. et al. (2006) High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res., 12, 989-995.
107. Van Tine, B. A., Kappes, J. C., Banerjee, N. S. et al. (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J. Virol., 78, 11172-11186.
108. Zheng, Z. M. and Baker, C. C. (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci., 11, 2286-2302.
109. Kalantari, M., Calleja-Macias, I. E., Tewari, D., Hagmar, B., Lie, K., Barrera-Saldana, H. A., Wiley, D. J. and Bernard, H. U. (2004) Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol., 78, 12762-12772.
110. Wiley, D. J., Huh, J., Rao, J. Y., Chang, C., Goetz, M., Poulter, M., Masongsong, E., Chang, C. I. and Bernard, H. U. (2005) Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J. Acquir. Immune Defic. Syndr., 39, 143-151.
111. Zhou, L., Jiang, W., Ren, C., Yin, Z., Feng, X., Liu, W., Tao, Q. and Yao, K. (2005) Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia, 7, 809-815.
112. Zazula, M., Ferreira, A. M., Czopek, J. P. et al. (2006) CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion. Diagn. Mol. Pathol., 15, 24-29.
113. Jicai, Z., Zongtao, Y., Jun, L., Haiping, L., Jianmin, W. and Lihua, H. (2006) Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma. Mol. Carcinog., 45, 530-536.
114. Zhang, J., Martins, C. R., Fansler, Z. B., Roemer, K. L., Kincaid, E. A., Gustafson, K. S., Heitjan, D. F. and Clark, D. P. (2005) DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma. Clin. Cancer Res., 11, 6544-6549.
115. Feng, Q., Balasubramanian, A., Hawes, S. E. et al. (2005) Detection of hypermethylated genes in women with and without cervical neoplasia. J. Natl. Cancer Inst., 97, 273-282.
116. Sugiyama, A., Maruta, F., Ikeno, T., Ishida, K., Kawasaki, S., Katsuyama, T., Shimizu, N. and Tatematsu, M. (1998) Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res., 58, 2067-2069.
117. Szaleczky, E., Pronai, L., Molnar, B., Berczi, L., Feher, J. and Tulassay, Z. (2000) Increased cell proliferation in chronic Helicobacter pylori positive gastritis and gastric carcinoma-correlation between immunohistochemistry and Tv image cytometry. Anal. Cell. Pathol., 20, 131-139.
118. Issa, J. P., Ahuja, N., Toyota, M., Bronner, M. P. and Brentnall, T. A. (2001) Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res., 61, 3573-3577.
119. Velicescu, M., Weisenberger, D. J., Gonzales, F. A., Tsai, Y. C., Nguyen, C. T. and Jones, P. A. (2002) Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res., 62, 2378-2384.
120. Song, M. J., Li, X., Brown, H. J. and Sun, R. (2002) Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol., 76, 5000-5013.
121. De Smet, C., Loriot, A. and Boon, T. (2004) Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol. Cell. Biol., 24, 4781-4790.
122. Zhang, Y. J., Ahsan, H., Chen, Y., Lunn, R. M., Wang, L. Y., Chen, S. Y., Lee, P. H., Chen, C. J. and Santella, R. M. (2002) High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol. Carcinog., 35, 85-92.
123. Zhang, Y. J., Chen, Y., Ahsan, H., Lunn, R. M., Lee, P. H., Chen, C. J. and Santella, R. M. (2003) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma. Int. J. Cancer, 103, 440-444.
124. Zhang, Y. J., Rossner, P.Jr, Chen, Y., Agrawal, M., Wang, Q., Wang, L., Ahsan, H., Yu, M. W., Lee, P. H. and Santella, R. M. (2006) Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. Int. J. Cancer, 119, 985-991.
125. Hu, W., Feng, Z. and Tang, M. S. (2003) Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms. Biochemistry, 42, 10012-10023.
126. Waterland, R. A. (2006) Assessing the effects of high methionine intake on DNA methylation. J. Nutr., 136, 1706S-1710S.
127. Reik, W., Dean, W. and Walter, J. (2001) Epigenetic reprogramming in mammalian development. Science, 293, 1089-1093.
128. Waterland, R. A. and Jirtle, R. L. (2003) Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol., 23, 5293-5300.
129. Ingrosso, D., Cimmino, A., Perna, A. F. et al. (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet, 361, 1693-1699.
130. Bird, A. P. (1995) Gene number, noise reduction and biological complexity. Trends Genet., 11, 94-100.
131. Yoder, J. A., Walsh, C. P. and Bestor, T. H. (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13, 335-340.
132. Smit, A. F. (1999) Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev., 9, 657-663.
133. Liu, W. M., Chu, W. M., Choudary, P. V. and Schmid, C. W. (1995) Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res., 23, 1758-1765.
134. Chu, W. M., Ballard, R., Carpick, B. W., Williams, B. R. and Schmid, C. W. (1998) Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. Mol. Cell. Biol., 18, 58-68.
135. Guarente, L. and Picard, F. (2005) Calorie restriction-the SIR2 connection. Cell, 120, 473-482.
136. Baur, J. A., Pearson, K. J., Price, N. L. et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
137. Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S. H., Watkins, D. N., Herman, J. G. and Baylin, S. B. (2006) Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet., 2, e40.
138. Olaharski, A. J., Rine, J., Marshall, B. L., Babiarz, J., Zhang, L., Verdin, E. and Smith, M. T. (2005) The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases. PLoS Genet., 1, e77.
139. Haigis, M. C. and Guarente, L. P. (2006) Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev., 20, 2913-2921.
140. Farber, E. (1996) Alcohol and other chemicals in the development of hepatocellular carcinoma. Clin. Lab. Med., 16, 377-394.
141. van Engeland, M., Weijenberg, M. P., Roemen, G. M., Brink, M., de Bruine, A. P., Goldbohm, R. A., van den Brandt, P. A., Baylin, S. B., de Goeij, A. F. and Herman, J. G. (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res., 63, 3133-3137.
142. Giovannucci, E., Rimm, E. B., Ascherio, A., Stampfer, M. J., Colditz, G. A. and Willett, W. C. (1995) Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J. Natl. Cancer Inst., 87, 265-273.
143. Puri, S. K., Si, L., Fan, C. Y. and Hanna, E. (2005) Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am. J. Otolaryngol., 26, 12-17.
144. Marsit, C. J., McClean, M. D., Furniss, C. S. and Kelsey, K. T. (2006) Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int. J. Cancer, 119, 1761-1766.
145. Dannenberg, L. O., Chen, H. J., Tian, H. and Edenberg, H. J. (2006) Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. Alcohol. Clin. Exp. Res., 30, 928-937.
146. Duhl, D. M., Vrieling, H., Miller, K. A., Wolff, G. L. and Barsh, G. S. (1994) Neomorphic agouti mutations in obese yellow mice. Nat. Genet., 8, 59-65.
147. Wolff, G. L., Kodell, R. L., Moore, S. R. and Cooney, C. A. (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J., 12, 949-957.
148. Michaud, E. J., van Vugt, M. J., Bultman, S. J., Sweet, H. O., Davisson, M. T. and Woychik, R. P. (1994) Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev., 8, 1463-1472.
149. Siracusa, L. D., Washburn, L. L., Swing, D. A., Argeson, A. C., Jenkins, N. A. and Copeland, N. G. (1995) Hypervariable yellow (Ahvy), a new murine agouti mutation: Ahvy displays the largest variation in coat color phenotypes of all known agouti alleles. J. Hered., 86, 121-128.
150. Millar, S. E., Miller, M. W., Stevens, M. E. and Barsh, G. S. (1995) Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development, 121, 3223-3232.
151. Cooney, C. A., Dave, A. A. and Wolff, G. L. (2002) Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr., 132, 2393S-2400S.
152. Waterland, R. A. and Jirtle, R. L. (2004) Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition, 20, 63-68.
153. Gaudet, F., Rideout, W. M.III, Meissner, A., Dausman, J., Leonhardt, H. and Jaenisch, R. (2004) Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing. Mol. Cell. Biol., 24, 1640-1648.
154. Rakyan, V. K., Chong, S., Champ, M. E., Cuthbert, P. C., Morgan, H. D., Luu, K. V. and Whitelaw, E. (2003) Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc. Natl. Acad. Sci. USA, 100, 2538-2543.
155. Campbell, J. H. and Perkins, P. (1988) Transgenerational effects of drug and hormonal treatments in mammals: a review of observations and ideas. Prog. Brain Res., 73, 535-553.
156. Morgan, H. D., Sutherland, H. G., Martin, D. I. and Whitelaw, E. (1999) Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet., 23, 314-318.
157. Rakyan, V. and Whitelaw, E. (2003) Transgenerational epigenetic inheritance. Curr. Biol., 13, R6.
158. Pembrey, M. E., Bygren, L. O., Kaati, G., Edvinsson, S., Northstone, K., Sjostrom, M. and Golding, J. (2006) Sex-specific, male-line transgenerational responses in humans. Eur. J. Hum. Genet., 14, 159-166.
159. Kaati, G., Bygren, L. O. and Edvinsson, S. (2002) Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur. J. Hum. Genet., 10, 682-688.
160. Sollars, V., Lu, X., Xiao, L., Wang, X., Garfinkel, M. D. and Ruden, D. M. (2003) Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat. Genet., 33, 70-74.
161. Rutherford, S. L. and Henikoff, S. (2003) Quantitative epigenetics. Nat. Genet., 33, 6-8.
162. Wilson, V. L. and Jones, P. A. (1983) DNA methylation decreases in aging but not in immortal cells. Science, 220, 1055-1057.
163. Mays-Hoopes, L., Chao, W., Butcher, H. C. and Huang, R. C. (1986) Decreased methylation of the major mouse long interspersed repeated DNA during aging and in myeloma cells. Dev. Genet., 7, 65-73.
164. Wilson, V. L., Smith, R. A., Ma, S. and Cutler, R. G. (1987) Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem., 262, 9948-9951.
165. Barbot, W., Dupressoir, A., Lazar, V. and Heidmann, T. (2002) Epigenetic regulation of an IAP retrotransposon in the aging mouse: progressive demethylation and de-silencing of the element by its repetitive induction. Nucleic Acids Res., 30, 2365-2373.
166. Issa, J. P., Vertino, P. M., Boehm, C. D., Newsham, I. F. and Baylin, S. B. (1996) Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl. Acad. Sci. USA, 93, 11757-11762.
167. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E. and Baylin, S. B. (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet., 7, 536-540.
168. Bennett-Baker, P. E., Wilkowski, J. and Burke, D. T. (2003) Age-associated activation of epigenetically repressed genes in the mouse. Genetics, 165, 2055-2062.
169. Wareham, K. A., Lyon, M. F., Glenister, P. H. and Williams, E. D. (1987) Age related reactivation of an X-linked gene. Nature, 327, 725-727.
170. Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R. and Feinberg, A. P. (2003) Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science, 299, 1753-1755.
171. Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S., Ohlsson, R., Longo, D. L. and Feinberg, A. P. (2005) Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science, 307, 1976-1978.
172. King, C. M., Gillespie, E. S., McKenna, P. G. and Barnett, Y. A. (1994) An investigation of mutation as a function of age in humans. Mutat. Res., 316, 79-90.
173. Fraga, M. F., Ballestar, E., Paz, M. F. et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad.
174. Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Jung, W. E., Li, E., Weinberg, R. A. and Jaenisch, R. (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell, 81, 197-205.
175. van Steensel, B. and Henikoff, S. (2003) Epigenomic profiling using microarrays. Biotechniques, 35, 346-357.
176. Riboli, E. and Kaaks, R. (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int. J. Epidemiol., 26 (Suppl 1), S6-S14.
177. Hung, R. J., Brennan, P., Canzian, F. et al. (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst., 97, 567-576.
178. Hung, R. J., van der Hel, O., Tavtigian, S. V., Brennan, P., Boffetta, P. and Hashibe, M. (2005) Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat. Res., 592, 102-118.
179. Scelo, G., Constantinescu, V., Csiki, I. et al. (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control, 15, 445-452.